Stockreport

UPDATE 1-Seelos Therapeutics' ALS treatment fails in mid-stage study [Yahoo! Finance]

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report
PDF March 19 (Reuters) - Seelos Therapeutics' experimental drug for a neurological disorder called ALS, or amyotrophic lateral sclerosis, failed to meet the main goal in a [Read more]